baber/WOPTO huggingface dataset:
Patent AR-019193-A1 (AR)
Title: Metodo para transmitir paquetes de informacion en un dispositivo de comunicacion y dispositivo de comunicacion usado en el mismo
IPC: H03M13/00
Filed: 1999-08-25
Abstract: Un método para transmitir paquetes de informacion en un dispositivo de comunicacion, el método comprende los pasos de: suministrar informacion alusuario para ser transmitida; dividir la informacion del usuario en al menos dos bloques de datos; determinar una primera capa de deteccion de error paracada uno de al menos dos bloques de datos para producir una pluralidad de primera capa de detecciones de errores; determinar una segunda capa de deteccionde error para cada una de al menos dos bloques de datos para producir una pluralidad de segunda capa de detecciones de errores, la pluralidad desegunda capa de detecciones de errores es distinta de la pluralidad de la primera capa de detecciones de errores; determinar un codigo proteccionsecundaria basado en la pluralidad de segunda capa de detecciones de error; y transmitir un paquete de informacion que incluye al menos dosbloques de datos, la pluralidad de la primera capa de detecciones de errores, y al menos una porcion de codigo de proteccion secundario en orden deincrementar una probabilidad de recuperar la informacion del usuario en el dispositivo de comunicacion receptor. Un dispositivo de comunicacion usadoen el método y que comprende: una fuente de informacion para proporcionarla informacion del usuario a ser transmitida; un procesador, unido a lafuente de informacion, que recibe la informacion del usuario, divide la informacion del usuario en una pluralidad de bloques de datos, determina una primeracapa de detecciones deerrores para cada una de la pluralidad de bloques de datos para producir una pluralidad de primera capa de detecciones deerrores, determina una segunda capa de detecciones de errores para cada una de la pluralidad de bloques de datos para producir una pluralidad de segundacapa de detecciones de errores, la pluralidad de segunda capa de detecciones de errores es distina de la pluralidad de primera capa de detecciones deerrores, y determina un codigo de proteccion secundario en base a la pluralidad de segunda capa de detecciones de errores; y un transmisor, unido al
Patent AR-020824-A1 (AR)
Title: Prevencion de la deficiencia de vitamina a funcional inducida por uv a traves del uso de un retinoide aplicado en forma topica
Filed: 1999-10-14
Abstract: El ácido todo-trans retinoico (RA) del metabolismo de la vitamina A es crítico para la funcion normal de la piel. La irradiacion ultravioleta (UV) reducemarcadamente el mRNA y proteína de los dos receptores retinoides nucleares más importantes,RAR-g ama y RXR-alfa en la piel humana in vivo. La mitad de la dosisde UV que causa el enrojecimiento de la piel fue suficiente para reducir los niveles de mRNA del receptor retinoide. La máxima reduccion de las proteínasRAR-gama y RXR-alfa ocurrioentre l as 8 y 16 horas, luego de la irradiacion de UV. Con multiples exposiciones a UV, RXR-alfa permanecio disminuido, peroRAR-gama se recupero a niveles normales. La aplicacion de RA 24 horas antes de la exposicion de UV, evito parcialmente lapérdida de los receptores retinoidesnucleares. La irradiacion de UV evito completamente la induccion de RA de los dos genes regulados por el receptor retinoide, el ácido retinoico celular que unela proteína-II (CRABP-II) y RA 4-hidrolasa. Porcontraste, la irra diacion UV no afecto la induccion de 1,25-dihidroxivitamina D3 del gen regulado por elreceptor de la vitamina D, la vitamina O 24-hidroxilasa que indica que el UV interfiere selectivamente la senda que senala el retinoide. Estosdatos demuestranpor primera vez que el UV reduce específicamente los niveles receptores retinoides y dramáticamente suprimen la expresion del gen en respuesta al retinoide enla piel humana in vivo. En efecto, el UV causa una deficiencia funcional devitamina A que podrí a tener efectos nocivos sobre la funcion de la piel, lo cualcontribuye al fotoenvejecimiento de la piel y a la carcinogénesis, que puede aliviarse por la aplicacion de un retinoide antes de la exposicion.
Patent WO-2006034519-A1 (WO)
Title: Mehrfachreflexions-verzögerungsstrecke für einen laserstrahl sowie resonator bzw. kurzpuls-laservorrichtung mit einer solchen verzögerungsstrecke
Inventor: TEMPEA GABRIEL
IPC: H01S3/098
Filed: 2005-09-20
Abstract: Mehrfachreflexions-Verzögerungsstrecke (18) für einen Laserstrahl (15), mit Spiegelelementen zur mehrfachen Reflexion des Laserstrahls (15), um die Dimensionen eines Laserresonators (12) bei vorgegebener optischer Länge zu reduzieren, wobei die Spiegelelemente durch zwei einander gegenüberliegende, sich längserstreckende polierte Oberflächen (S2, S3) eines sich in einer Richtung erstreckenden Glaselements (21) gebildet sind, das weiters eine polierte Laserstrahl-Eintrittsfläche (S1) sowie eine polierte Laserstrahl-Austrittsfläche (S4) aufweist, wobei sich die Spiegelelement-Oberflächen (S2, S3) des Glaselements zwischen der Eintrittsfläche (S1) und der Austrittsfläche (S4) befinden und mit dem Laserstrahl (15) einen Winkel (?<sub
Patent WO-2013056293-A1 (WO)
Title: Hülse für eine rohrpostanlage mit einem hülsenrohr
Inventor: FRIEDRICH PETER
IPC: B65G51/06
Filed: 2012-10-19
Abstract: Hülse (1) für eine Rohrpostanlage mit einem Hülsenrohr (2), das mit mindestens einem Deckel, der aus mehreren Deckelsektoren (3) gebildet ist, verschlossen ist, wobei die Hülse (1) mittels eines Gleitrings (6) offenbar und schließbar ist, wobei der Gleitring (6) parallel zur Längsachse (9) der Hülse (1) bewegbar ist und das Hülsenrohr (2) umschließt. Die Deckelsektoren (3) bestehen aus je zwei Teilbereichen, nämlich aus einem ersten Teilbereich (4) und einem zweiten Teilbereich (5), wobei die ersten Teilbereiche (4) in Schließstellung das Hülsenrohr (2) abschließen. Die zweiten Teilbereiche (5) sind an die ersten Teilbereiche (4) angeformt und umfassen das Hülsenrohr (2) in einem Endabschnitt. Sie sind am Gleitrint (6) schwenkbar befestigt. Ein Klemmring (7) wirkt mit den zweiten Teilbereichen (5) der Deckelsektoren (3) in Schließposition formschlüssig zusammen und hält so die Deckelsektoren (3) geschlossen.
Patent WO-2018148772-A1 (WO)
Title: Coque en une seule pièce
Inventor: NAGL MANFRED
IPC: B32B5/02
Filed: 2018-02-12
Abstract: L'invention concerne un meuble, par exemple un meuble de rangement, destiné à un avion. Ce meuble comprend un corps, ce corps présentant au moins une partie de corps (100, 200) comprenant un fond supérieur et un fond inférieur formant des parois de délimitation, ainsi que des parties latérales. Selon l'invention, la ou les parties de corps (100, 200) sont composées d'au moins une couche (110, 210) qui comprend un ou plusieurs plis (120) constitués d'un composite renforcé de fibres dans une matrice de résine, appelés ci-après plis de composite renforcé de fibres, les extrémités (130) se rejoignant du ou des plis de composite renforcé de fibres (120) de la ou des couches (110, 210) étant reliées en aboutement et/ou en chevauchement de telle sorte que la ou les parties de corps (100, 200) sont formées en une seule pièce à partir de cette ou de ces couches (110, 210).
Patent WO-2020176915-A1 (WO)
Inventor: THUMFART HARALD
IPC: H02J7/00
Filed: 2020-02-28
Abstract: Es wird ein Akkumulatorsystem (1) mit einem Leistungsakkumulator (2) für fahrbare Arbeitsmaschinen mit einem einen Kontroller (3) aufweisenden Batteriemanagementsystem (4), mit mittels Schaltern (5) schaltbaren Leitungsanschlüssen (6) und mit einem Datenbus (7) zur Verbindung mit einer Arbeitsmaschinensteuerung (8) vorgeschlagen. Um vorteilhaft auf eine Bordbatterie verzichten zu können, wird vorgeschlagen, dass das Batteriemanagementsystem (4) zur Spannungsversorgung einen dem Kontroller (3) vorgeschalteten Gleichstromwandler (9) umfasst, der über eine Standby-Schaltung (10) an den Leistungsakkumulator (2) angeschlossen ist, wobei die Standby-Schaltung (10) über eine akkumulatorsystemexterne Schaltung (11) aktivierbar ist.
Patent AU-2002251866-A1 (AU)
Title: Methods and compositions for cleaning, rinsing, and antimicrobial treatment of medical equipment
Inventor: CHANDLER DENISE
IPC: C11D1/62
Filed: 2002-01-31
Abstract: The present invention relates to methods for cleaning, rinsing, and/or antimicrobial treatment of medical carts, medical cages, and other medical instruments, devices or equipment. The method for cleaning employs a solid alkaline, for example a solid carbonate, cleaning composition for cleaning the medical cart, cage, instrument, device, or equipment. The method for rinsing employs a solid neutral or neutralizing rinse composition for rinsing the medical cart, cage, instrument, device, or equipment. The method for antimicrobial treatment employs a solid, for example a solid quaternary ammonium or solid halogen, antimicrobial composition, for antimicrobial treatment of the medical cart, cage, instrument, device, or equipment.
Patent AU-2002358516-A1 (AU)
Title: Method and system for controlling a brake installation
Inventor: ENDRES FRANZ-JOSEF
IPC: B60T7/12
Filed: 2002-11-18
Abstract: The present invention provides a method and a system for controlling braking equipment with a function for the driveaway assistance of a motor vehicle. After setting an initial operating state of the braking equipment in which the function for the driveaway assistance is selectively switched on or off, an operating state of the motor vehicle in which the motor vehicle is stationary or nearly stationary is determined. If the motor vehicle is stationary and a characteristic control parameter capable of being influenced by the driver is detected, the braking equipment of the motor vehicle is controlled in such a way that, by switching on or off the function for the driveaway assistance of the motor vehicle, an operating state of the braking equipment differing from the initial operating state is produced.
Patent AU-2002364304-A1 (AU)
Title: Substituted diketopiperazines as oxytocin antagonists
Inventor: LIDDLE JOHN
IPC: C07D403/10
Filed: 2002-12-20
Abstract: A method of treating or preventing diseases or conditions mediated through the action of oxytocin which comprises administering to a human in need thereof of an effective amount of a compound of the formula (I) or a pharmaceutically acceptable salt thereof.
Patent AU-2003227008-A1 (AU)
Title: 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
Inventor: SUSILO RUDY
IPC: A61K31/425
Filed: 2003-02-24
Abstract: The invention relates to the compounds (2R,4R), (2S,4R)-2-methylthiazolidine-2,4-dicarboxylic acid and (2RS,4R)-2-methylthiazolidine-2,4-dicarboxylic acid and salts of said compounds, the use thereof for the prophylaxis and/or treatment of neurodegenerative diseases, methods for the prophylaxis and/or treatment of neurodegenerative diseases, and pharmaceutical compositions containing said compounds together with physiologically compatible carriers, auxiliary agents, and/or solvents.
Patent AU-2003235747-A1 (AU)
Title: Locking hinged joint for vapor-liquid contact trays
Inventor: EATON RAYMOND H JR
IPC: B01D3/32
Filed: 2003-01-08
Abstract: A vapor-liquid contact tray is provided with at least two tray panels that are releaseably together along their overlapped margins by a locking hinged joint. The joint is formed by fingers in one tray panel that extend through slots located in the other tray panel. Offset bends are formed in the tray panels so that the overlapped margins do not extend above the top surface of the tray. The hinged joint includes a locking mechanism that prevents lateral separation of the tray panels once they have been releaseably joined together. The locking mechanism is formed by a downturned locking flange positioned between the fingers in one of the tray panels and extending downwardly into and, preferably through, openings located in the overlapped margin of the other tray panel.
Patent AU-2003239769-A1 (AU)
Title: An optical element for shielding against light
Inventor: BEZZEL EIK
IPC: E06B9/24
Filed: 2003-06-18
Abstract: An optical element (11) in the form of an at least partially transparent face comprises transparent areas and essentially non-transparent areas. The transparent areas are arranged sufficiently close for the intermediate and essentially non-transparent areas to be essentially invisible to the naked eye, at least when the element is viewed from a given distance. The essentially non-transparent areas are arranged sufficiently close and have a sufficient extent at right angles to the face for the intermediate, transparent areas to have such depth/width ratio that the optical element will, at a given point on the face, allow passage of light with given angles of incidence, while light having other angles of incidence are unable to pass the element at the point in question. Hereby an optical element is obtained that is able to better reduce the heating of the interior of a building that is caused by incoming solar radiation without the direct radiation and hence the view being blocked considerably.
Patent AU-2003245959-A1 (AU)
Title: Method for the preparation of polyether alcohols
Inventor: GROTH IRIS
IPC: C08G65/30
Filed: 2003-06-18
Abstract: The invention relates to a process for the work-up of polyether alcohols which have been prepared by base-catalyzed addition of ethylene oxide and propylene oxide onto H-functional starter substances and have a proportion of ethylene oxide in the polyether chain of greater than 20% by weight, preferably greater than 25% by weight, particularly preferably greater than 35% by weight and in particular greater than 50% by weight, based on the weight of the alkylene oxides used, which comprises the steps a) neutralization of the polyether alcohol with an acid subsequent to the addition reaction of the alkylene oxides, b) addition of at least one absorbent, c) removal of water and volatile compounds from the polyether alcohol, d) removal of the salts formed and the absorbents from the polyether alcohol, wherein phosphoric acid is used as acid in step a) in an amount of from 56 to 98% of the stoichiometric amount, the absorbent is used in an amount of from 0.05 to 5% by weight, based on the polyether alcohol, in step b) and at least one alkali metal hydroxide, alkaline earth metal hydroxide or amine is added to the polyether alcohol in an amount of from 0.001 to 0.5% by weight, based on the weight of the polyetherol, during the course of step c).
Patent AU-2003246800-A1 (AU)
Title: Protection against oxidation of parts made of composite material
Inventor: THEBAULT JACQUES
IPC: F16D69/02
Filed: 2003-04-09
Abstract: An oxidation-sensitive composite has applied thereto a composition comprising a mixture of boride powder constituted for the most part of TiB2, at least one vitreous refractory oxide powder constituted for the most part by a mixture of borosilicate glass, and a binder containing a ceramic-precursor resin. The resin is cured and is subsequently transformed into a ceramic by heat treatment or during first exposure of the coated part to high temperatures.
Patent AU-2003264149-A1 (AU)
Title: Elongate retaining element
Inventor: DOHREN HANS-JURGEN
IPC: E04D3/362
Filed: 2003-08-29
Abstract: The invention relates to an elongate retaining element for building sheets, having, as seen in cross section perpendicular to its direction of elongation, a heard part (1) for engaging at least one said building sheets, a base part (3) for mounting the elongate retaining element on a support structure, and a connecting flange (2) extending upwardly from said base part (3) and joining said head part (1) to said base part (3). The elongate retaining element is made from a plastic material, such as PA, and has a reinforcement sheet (4), such as a metal sheet, extending from the connecting flange (2) into at least the head part (1). As seen in cross section, in the head part one free end (5) of the reinforcement sheet is bent into a section with an acute angle of less than 90°.
Patent AU-2003265186-A1 (AU)
Title: Detection of implanted injection port
Inventor: FORSELL PETER
IPC: A61B5/06
Filed: 2003-09-26
Abstract: An apparatus for detecting an injection port (12) subcutaneously implanted in a patient (13) comprises a magnetic device (15), such as a permanent magnet or a solenoid, that emits a local magnetic field, and a magnetic detector (17), preferably including at least one Hall element, that detects the local magnetic field. The magnetic device (15) is designed to be subcutaneously implanted in the patient at the implanted injection port (12), and the magnetic detector (17) is movable externally along the patient's body to establish an injection position at the patient's skin (16) in front of the implanted injection port where the local magnetic field emitted by the magnetic device is detected by the magnetic detector. As a result, an injection needle (14) can be placed in the established injection position, in order to insert the injection needle through the patient's skin (16) directly into the injection port substantially in the centre thereof.
Patent AU-2004212944-A1 (AU)
Title: Lipophilic drug delivery vehicle and methods of use thereof
Inventor: RYAN ROBERT O
IPC: A61K31/7048
Filed: 2004-02-13
Abstract: The invention provides compositions and methods for delivery of a bioactive agent to an individual. Delivery vehicles are provided that include a bioactive agent in disc shaped particles that include one or more lipid binding polypeptides circumscribing the perimeter of a lipid bilayer in which the bioactive agent is localized. Chimeric lipid binding polypeptides are also provided and may be used to add additional functional properties to the delivery particles.
Patent WO-2006037189-A1 (WO)
Inventor: JACOBS ANDREW
Filed: 2005-10-07
Abstract: The present invention relates to a vascular plant including cells expressing a Na+ pumping ATPase.
Patent AU-2005201076-A1 (AU)
Title: Cell for gas generation
Inventor: WEIGAND MICHAEL
IPC: C25B9/00
Filed: 2005-03-10
Abstract: Cells (I) for gas production (preferably for operating a lubricant dispenser), comprise two electrodes (1, 1'), which are connected at one end with a current source (2) containing electric circuit (3); and an azide compound containing aqueous electrolyte liquid (4) for electro-chemical production of a nitrogen (N 2) gas is situated between the two electrodes. Cells (I) for gas production (preferably for operating a lubricant dispenser), comprises two electrodes (1, 1'), which are connected at one end with a current source (2) containing electric circuit (3); and an azide compound of formula (XN 3) containing aqueous electrolyte liquid (4) for electro-chemical production of a nitrogen (N 2) gas is situated between the two electrodes, where the electrolyte liquid contains a magnesium salt as additive for the chemical bond with the electro-chemical reaction resulting hydroxide ions.
Patent AU-2005299597-A1 (AU)
Title: A tool box fastening device for fastening a tool box set to a vertical wall
Inventor: NGUY CHANWA
IPC: A47G29/02
Filed: 2005-10-26
Abstract: Disclosed is a tool box set fastener, which include a first fastening structure, which has mounting base fixedly fastened to a vertical wall or upright support and a coupling unit formed integral with the mounting base, and a second fastening structure, which is connectable to a tool box set to secure the tool box set to the first fastening structure and has a coupling base connectable to the coupling unit of the first fastening structure.
Patent WO-2006105589-A1 (WO)
Title: Organes de fermeture et de fixation
Inventor: RUDDUCK DICKORY
IPC: E05B51/00
Filed: 2006-04-04
Abstract: Cette invention concerne un dispositif de fixation amovible (10) comprenant une languette (20) mobile le long d’un premier rail entre une position verrouillée et une position déverrouillée, et une navette (24) mobile le long d’un second rail en angle par rapport au premier. La navette (24) est conçue pour se déplacer le long du second rail sous l’effet d’une pièce contractile en cas d’activation. Le dispositif de fixation amovible (10) comprend également un moyen reliant la languette (20) et la navette (24) de sorte que le déplacement de la navette (24) le long du second rail permette celui de la languette (20) le long du premier rail. Cette invention concerne également un dispositif de fixation amovible (50) pour la fixation amovible d’un premier élément (44) à un second élément (46). Ledit dispositif (50) comprend un premier moyen de fixation (56) pour le premier élément (44) et un second moyen de fixation (62, 66) pour le second élément (46). Le second moyen de fixation (62, 66) est mobile le long d’un premier rail entre une position verrouillée, où ledit moyen (62, 66) s’emboîte dans le premier moyen de fixation (56), et une position déverrouillée, où le second moyen de fixation (62, 66) se désaccouple du premier (56). Le dispositif de fixation amovible (50) comprend également une navette (64) mobile le long d’un second rail en angle par rapport au premier et un moyen reliant le second moyen de fixation (62, 66) et la navette (64) de sorte que le déplacement de la navette (64) le long du second rail permette celui du second moyen de fixation (62, 66) le long du premier rail. Le dispositif de fixation amovible (10 ou 50) peut comprendre un élément de réduction de la déformation.
Patent AU-2006249009-A1 (AU)
Title: Methods for producing alkyl(meth)acrylates
Inventor: MAY ALEXANDER
IPC: C07C69/54
Filed: 2006-05-12
Abstract: The present invention relates to processes for preparing alkyl (meth)acrylates, comprising the steps of transesterifying an alkyl α-hydroxycarboxylate with (meth)acrylic acid to obtain alkyl (meth)acrylates and α-hydroxycarboxylic acid, and dehydrating the α-hydroxycarboxylic acid to obtain (meth)acrylic acid.
Patent AU-2006273918-A1 (AU)
Title: Method for affinity chromatography of antithrombin III
Inventor: MOURIER PIERRE
IPC: B01J20/28
Filed: 2006-07-26
Abstract: The present invention is directed to an affinity chromatography column comprising the antithrombin III (ATIII) protein bound to a solid support, characterized in that: a. the ATIII protein is the wild-type protein or a variant thereof, b. the ATIII protein has been first activated by incubation with an unmodified low-molecular-weight heparin (LMWH) rich in active species, and c. the ATIII protein is covalently bound to a resin in a ratio of less than approximately 2 mg of protein per ml of hydrated resin. The invention is also directed to the use of the aforesaid column for purifying species having an affinity for ATIII in a sample comprising species having affinity and not having affinity for ATIII.
Patent AU-2006322451-A1 (AU)
Title: Method for generating dendritic cells employing decreased temperature
Inventor: ZEUTHEN JESPER
IPC: A61K39/00
Filed: 2006-12-07
Abstract: The invention relates in certain embodiments to a method for generating dendritic cells by employing temperatures below 37° C. during the development of progenitor cells and immature dendritic cells. In some embodiments the invention relates to populations of dendritic cells and its use.
Patent WO-2008070892-A1 (WO)
Inventor: RAYNER TIMOTHY EDWARD
IPC: A61K38/39
Filed: 2007-09-12
Abstract: The present invention relates to a method of promoting production of one or more components of extracellular matrix by a fibroblast cell and/or promoting migration of a fibroblast cell. The method includes exposing the fibroblast cell to an effective amount of an agent with peroxidase activity.
Patent WO-2008055314-A1 (WO)
Title: Hétéro-dimères/-oligomères de récepteur à hormone de libération de la thyrotropine et de récepteur à orexine
Inventor: PFLEGER KEVIN DONALD GEORGE
IPC: G01N33/78
Filed: 2007-11-09
Abstract: Récepteur hétéro-dimérique ou hétéro-oligomérique, comprenant au moins une sous-unité du récepteur à hormone de libération de la thyrotropine avec au moins une sous-unité du récepteur à orexine.